NCT03925922 is a clinical trial in Fetal Fibronectin (Ffn), sponsored by Ain Shams University.

Who is sponsoring NCT03925922?

NCT03925922 is sponsored by Ain Shams University.

What condition does NCT03925922 study?

NCT03925922 studies Fetal Fibronectin (Ffn).

Is NCT03925922 still recruiting?

NCT03925922 is currently completed. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT03925922

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Fetal Fibronectin (Ffn) vs Cervical Length in Patient With Unfavourable Cervix in Prediction of Successful Induction of Labor

Completed Last updated 28 August 2019

What this trial tests

trial in Fetal Fibronectin (Ffn) in 40 participants. Completed in 15 August 2019.

Timeline

26 April 2019

Primary endpoint
30 July 2019

15 August 2019

Quick facts

Lead sponsor	Ain Shams University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	26 April 2019
Primary completion	30 July 2019
Estimated completion	15 August 2019
Sites	1 location across Egypt

Conditions studied

Fetal Fibronectin (Ffn) — all drugs for Fetal Fibronectin (Ffn) →

Sponsor

Ain Shams University

Who can join

Adults 18 to 45, female only, with Fetal Fibronectin (Ffn). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the efficacy of fFN compared to transvaginal ultrasound of cervix in prediction of successful induction of labor for unfavorable cervix (bishop score 5 or less).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03925922 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03925922.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing